These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 20085389)

  • 41. Coverage with evidence development: an examination of conceptual and policy issues.
    Hutton J; Trueman P; Henshall C
    Int J Technol Assess Health Care; 2007; 23(4):425-32. PubMed ID: 17937829
    [TBL] [Abstract][Full Text] [Related]  

  • 42. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The use of economic evaluations in NHS decision-making: a review and empirical investigation.
    Williams I; McIver S; Moore D; Bryan S
    Health Technol Assess; 2008 Apr; 12(7):iii, ix-x, 1-175. PubMed ID: 18373906
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Negotiating commissioning pathways for the successful implementation of innovative health technology in primary care.
    Maniatopoulos G; Haining S; Allen J; Wilkes S
    BMC Health Serv Res; 2019 Sep; 19(1):648. PubMed ID: 31492139
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The experience of adults who choose watchful waiting or active surveillance as an approach to medical treatment: a qualitative systematic review.
    Rittenmeyer L; Huffman D; Alagna M; Moore E
    JBI Database System Rev Implement Rep; 2016 Feb; 14(2):174-255. PubMed ID: 27536798
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Innovative patient access schemes for the adoption of new technology: risk-sharing agreements].
    Espín J; Oliva J; Rodríguez-Barrios JM
    Gac Sanit; 2010; 24(6):491-7. PubMed ID: 21074292
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Looking at CER from Medicare's perspective.
    Mohr P
    J Manag Care Pharm; 2012 May; 18(4 Suppl A):S5-8. PubMed ID: 22578211
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Integration of economic appraisal and health care policy in a health insurance system; the Dutch case.
    Rutten F; van der Linden JW
    Soc Sci Med; 1994 Jun; 38(12):1609-14. PubMed ID: 8047918
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reimbursement of Drugs for Rare Diseases through the Public Healthcare System in Canada: Where Are We Now?
    Menon D; Clark D; Stafinski T
    Healthc Policy; 2015 Aug; 11(1):15-32. PubMed ID: 26571466
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Revolution then evolution: the advance of health economic evaluation in Australia.
    Lopert R; Viney R
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):360-6. PubMed ID: 25444293
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Technology assessment in Catalonia: integrating economic appraisal.
    Granados A; Borràs JM
    Soc Sci Med; 1994 Jun; 38(12):1643-6. PubMed ID: 8047922
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Introduction of emerging medical devices on the market: a new procedure in Belgium.
    Vinck I; Neyt M; Thiry N; Louagie M; Ramaekers D
    Int J Technol Assess Health Care; 2007; 23(4):449-54. PubMed ID: 17937833
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Implementing evidence-based medicine through medicare coverage decisions.
    Foote SB; Town RJ
    Health Aff (Millwood); 2007; 26(6):1634-42. PubMed ID: 17978383
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of health technology: economic issues for health policy and policy issues for economic appraisal.
    Drummond M
    Soc Sci Med; 1994 Jun; 38(12):1593-600. PubMed ID: 8047916
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The HTA Risk Analysis Chart: Visualising the Need for and Potential Value of Managed Entry Agreements in Health Technology Assessment.
    Grimm SE; Strong M; Brennan A; Wailoo AJ
    Pharmacoeconomics; 2017 Dec; 35(12):1287-1296. PubMed ID: 28849538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Demand-side financing measures to increase maternal health service utilisation and improve health outcomes: a systematic review of evidence from low- and middle-income countries.
    Murray SF; Hunter BM; Bisht R; Ensor T; Bick D
    JBI Libr Syst Rev; 2012; 10(58):4165-4567. PubMed ID: 27820523
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-effectiveness analysis: from science to application.
    Berger ML; Teutsch S
    Med Care; 2005 Jul; 43(7 Suppl):49-53. PubMed ID: 16056009
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 360-degree Delphi: addressing sociotechnical challenges of healthcare IT.
    Waldmüller H; Spreckelsen C; Rudat H; Krumm N; Rolke R; Jonas SM
    BMC Med Inform Decis Mak; 2020 Jun; 20(1):101. PubMed ID: 32503609
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Medicare is scrutinizing evidence more tightly for national coverage determinations.
    Chambers JD; Chenoweth M; Cangelosi MJ; Pyo J; Cohen JT; Neumann PJ
    Health Aff (Millwood); 2015 Feb; 34(2):253-60. PubMed ID: 25646105
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.